top of page
Search
  • Writer's pictureARQon
    • Mar 28, 2019
    • 1 min read

China NMPA Innovation Pathway Document List


In December 2018, China's National Medical Products Administration (NMPA) released the Special Medical Device Special Review Procedure (No. 83 of 2018), as part of their efforts to encourage innovation in medical device research and development. This revision to the"Innovative Medical Device Special Review Procedures" will abolish the previous "Special Approval Procedure for Innovative Medical Devices (Trial)" (Food and Drug Administration [2014] No. 13).

ARQon has summarised the submission document list for easy reference. Check out the following link for the document list:

Contact us at info@arqon.com.


160 views0 comments

Recent Posts

See All

China Clinical Requirements Update

China Clinical Requirements Update On 13th December, the CMDE published the Public Consultation (Deadline: 13 Jan 2020) on “Technical Guidance on Using Real-World Data for Clinical Evaluation of Medic

Asia, Africa & Middle East - Nov/Dec 2019

Australia: Proposed changes to the Essential Principles for safety and performance Australia: Proposed changes to the requirements for systems and procedure packs Australia: Feedback sought on the reg

Asia, Africa & Middle East - Aug 2019

Australia: 2019 fees and charges released by the Therapeutic Goods Administration Australia: Conformity assessment standards for medical device QMSs Australia: TGA will no longer send out annual repor

bottom of page